DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 11 Jul · 12:47 IST

Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Divi's Laboratories has published newspaper notices informing shareholders about its 35th Annual General Meeting scheduled for August 11, 2025, at 10:00 AM via Video Conferencing. The Board has recommended a dividend of ₹30 per equity share of ₹2 face value (1500%) for FY 2024-25, subject to shareholder approval at the AGM. The record date for determining dividend eligibility has been fixed as July 25, 2025. If approved, dividend payment will begin on/after August 16, 2025, through electronic mode after deducting tax at source. Shareholders are reminded that KYC updates (PAN, bank details, nomination) are mandatory to receive the dividend, and the Annual Report 2024-25 will be sent electronically only.

Likely market impact

This is a positive announcement for shareholders — a ₹30 dividend on a ₹2 face value reflects a robust 1500% payout, signaling strong cash generation. Investors must hold shares by the July 25, 2025 record date to qualify, and the stock may see ex-date adjustment post-record date.